fda warning letters glp-1 compounding september 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading fda warning letters glp-1 compounded

Basal insulin is a highly effective treatment in reducing fasting blood glucose, but it is associated with considerable risk of hypoglycemia and weight gain

Explain briefly: This is my prescribed injectable medication for diabetes management [or weight management]

It should be mentioned that all the most effective GLP-1 drugs are currently delivered using injectable pens, which makes this type of drug delivery system more popular among healthcare professionals and patients

For most patients with obesity, the cardiovascular and metabolic benefits of these medications substantially outweigh theoretical concerns about blood clots, which are not supported by current evidence

But heres the twist even when the scale barely moves, exercise reliably reduces waist size, body fat, and improves health markers